尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by James Andrea S.. Insider active across 2 companies, notably OncoCyte Corp. Aggregated, 6 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €327k. History available since 2 October 2024. The latest transaction was disclosed on 31 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
James Andrea S. is a declarant linked to Insight Molecular Diagnostics Inc. and OncoCyte Corp, where he is Chief Financial Officer. The 6 filings in the recent sample cover the period from 2024-10-04 to 2026-03-30, with EUR 326642 of buys and EUR 0 of sells, and the most frequent transaction nature is option exercise.